Proliferation of SARS-CoV-2 B.1.1.7 Variant in Pakistan-A Short Surveillance Account.


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
Historique:
received: 20 03 2021
accepted: 10 05 2021
entrez: 17 6 2021
pubmed: 18 6 2021
medline: 24 6 2021
Statut: epublish

Résumé

The emergence of a more transmissible variant of SARS-CoV-2 (B1. 1.7) in the United Kingdom (UK) during late 2020 has raised major public health concerns. Several mutations have been reported in the genome of the B.1.1.7 variant including the N501Y and 69-70deletion in the Spike region that has implications on virus transmissibility and diagnostics. Although the B.1.1.7 variant has been reported by several countries, only three cases have been reported in Pakistan through whole-genome sequencing. Therefore, the objective of the study was to investigate the circulation of B.1.1.7 variant of concern (VOC) in Pakistani population. We used a two-step strategy for the detection of B.1.1.7 with initial screening through TaqPath

Identifiants

pubmed: 34136461
doi: 10.3389/fpubh.2021.683378
pmc: PMC8200564
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

683378

Informations de copyright

Copyright © 2021 Umair, Salman, Rehman, Badar, Ali, Ahad and Ikram.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Med Virol. 2021 May;93(5):2623-2625
pubmed: 33570181
Cell. 2021 Mar 4;184(5):1127-1132
pubmed: 33581746
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Mol Biol Evol. 2008 Jul;25(7):1253-6
pubmed: 18397919
Lancet Respir Med. 2021 Feb;9(2):e20-e21
pubmed: 33417829
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Science. 2020 Aug 21;369(6506):1014-1018
pubmed: 32540904
Mol Phylogenet Evol. 1997 Dec;8(3):398-414
pubmed: 9417897
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
Nature. 2020 Dec;588(7839):682-687
pubmed: 33045718
J Travel Med. 2021 Feb 23;28(2):
pubmed: 33506254
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Lancet. 2021 Apr 10;397(10282):1351-1362
pubmed: 33798499
JAMA. 2021 Feb 9;325(6):529-531
pubmed: 33404586

Auteurs

Massab Umair (M)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Muhammad Salman (M)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Zaira Rehman (Z)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Nazish Badar (N)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Qasim Ali (Q)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Abdul Ahad (A)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Aamer Ikram (A)

Department of Virology, National Institute of Health, Islamabad, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH